Home > Journals > Minerva Endocrinologica > Past Issues > Minerva Endocrinologica 2006 September;31(3) > Minerva Endocrinologica 2006 September;31(3):191-209

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

ORIGINAL ARTICLES   

Minerva Endocrinologica 2006 September;31(3):191-209

Copyright © 2006 EDIZIONI MINERVA MEDICA

language: English, Italian

Safety and efficacy of administering 0.2 mg of recombinant human TSH for two consecutive days as an adjuvant to therapy with low radioiodine doses in elderly out-patients with large nontoxic multinodular goiter

Giusti M. 1, Cappi C. 1, Santaniello B. 2, Ceresola E. 1, Augeri C. 2, Lagasio C. 1, Minuto F. 1


To access the FULL TEXT of this article choose one of the two following options:

PURCHASE THE ARTICLE

You can access the full text of this article (PDF and HTML if available) for 2 days at a price of:  € 50,00.

INDIVIDUAL SUBSCRIBERS/MEMBERS LOGIN


TO SUBSCRIBE

top of page